Ranbaxy is India's largest pharmaceutical company, specializing in the production of affordable generic medicines. With a presence in 49 countries and manufacturing facilities in 11 countries, it serves customers in over 125 countries. In 2008, it formed an alliance with Daiichi Sankyo Company Ltd., propelling it into the top 15 pharmaceutical companies globally. Ranbaxy aims to achieve significant business in proprietary prescription products and aspires to be among the top 5 global generic players with a target of US $5 Bn in global sales by 2012. The company was founded in 1961 and had global sales of US $ 1,682 Mn in 2008, with 54% of revenues from emerging markets and 39% from developed markets. Its key markets included North America, Europe, and India, where it achieved market leadership in several business segments. Ranbaxy's alliance has positioned it for higher growth and enhanced capabilities in drug development and manufacturing.
There is no investment information
No recent news or press coverage available for Ranbaxy.
We care about your data, and we'd love to use cookies make your experience better.
